The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Prerequisite for Cardiac Aldosterone Action: Mineralocorticoid Receptor and 11β-Hydroxysteroid Dehydrogenase in the Human Heart
Abstract
Background It has been proposed that aldosterone exerts direct effects on heart function, most notably on the development of myocardial fibrosis during ventricular hypertrophy in rat. Initial events in aldosterone action entail its binding to mineralocorticoid receptor (MR). Because MR displays similar affinities for aldosterone and glucocorticoids, the in vivo aldosterone selectivity of MR requires the presence of an enzyme, 11β-hydroxysteroid dehydrogenase (11-HSD), which metabolizes glucocorticoids into inactive derivatives. Although evidence exists for the presence of MR in rodent heart, no data are available for humans; moreover, the existence of cardiac 11-HSD is controversial. Methods and Results The heart samples used originated from tissue removed during cardiac surgery in nontransplant patients or from endocavitary biopsies done for the follow-up of heart transplantation. The expression of MR was examined at the mRNA and protein level by in situ hybridization with cRNA probes specific for human MR mRNA and by immunodetection with two specific anti-MR antibodies. 11-HSD catalytic activity was determined by measurement of the metabolic rate of tritiated corticosteroids by cardiac samples. In nontransplanted hearts, an in situ hybridization signal equivalent to that found in the whole kidney was present on cardiomyocytes. Specific immunolabeling of cardiomyocytes with anti-MR antibodies demonstrated the presence of the MR protein. Cardiac 11-HSD activity was detected (243±26 fmol · 30 min−1· mg protein−1) and was dependent on the cofactor NAD, not NADP, suggesting that it corresponds to the form of the enzyme specifically responsible for MR protection. In transplanted hearts that presented severe alterations, MR immunodetection was weaker and irregular, with no specific hybridization signal. Conclusions Our results demonstrate that MR is coexpressed with 11-HSD in human heart, which thus possesses the cellular machinery required for direct aldosterone action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Arriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946
Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated
Funder, J. W., Pearce, P. T., Smith, R., & Smith, A. I. (1988) · Science · doi:10.1126/science.2845584 · Cited by 1,628
Adrenal steroid receptors and actions in the nervous system
McEwen, B. S., De Kloet, E. R., & Rostene, W. (1986) · Physiological Reviews · doi:10.1152/physrev.1986.66.4.1121 · Cited by 1,232
Swedberg, K., Eneroth, P., Kjekshus, J., & Wilhelmsen, L. (1990) · Circulation · doi:10.1161/01.cir.82.5.1730 · Cited by 1,153
Edwards, C. R. W., Burt, D., Mcintyre, M. A., De Kloet, E. R., Stewart, P. M., Brett, L., Sutanto, W. S., & Monder, C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90742-8 · Cited by 1,068
Brilla, C. G., Zhou, G., Matsubara, L., & Weber, K. T. (1994) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1994.1098 · Cited by 694
Remodeling of the rat right and left ventricles in experimental hypertension.
Brilla, C. G., Pick, R., Tan, L. B., Janicki, J. S., & Weber, K. T. (1990) · Circulation Research · doi:10.1161/01.res.67.6.1355 · Cited by 674
Mineralocorticoid excess, dietary sodium, and myocardial fibrosis.
Brilla, C. G., & Weber, K. T. (1992) · PubMed · Cited by 505
Mineralocorticoids, hypertension, and cardiac fibrosis.
Young, M., Fullerton, M., Dilley, R., & Funder, J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117269 · Cited by 437
Brilla, C. G., Matsubara, L. S., & Weber, K. T. (1993) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1993.1066 · Cited by 425
Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor.
Lombès, M., Oblin, M. E., Gasc, J. M., Baulieu, E. E., Farman, N., & Bonvalet, J. P. (1992) · Circulation Research · doi:10.1161/01.res.71.3.503 · Cited by 309
Self-citationBrown, R. W., Chapman, K. E., Edwards, C. R., & Seckl, J. R. (1993) · Endocrinology · doi:10.1210/endo.132.6.8504762 · Cited by 271
A new isoform of 11 beta-hydroxysteroid dehydrogenase in aldosterone target cells
Rusvai, E., & Náray-Fejes-Tóth, A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82044-0 · Cited by 248
MOISAN, M.-P., SECKL, J. R., & EDWARDS, C. R. W. (1990) · Endocrinology · doi:10.1210/endo-127-3-1450 · Cited by 221
Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension.
Robert, V, Van Thiem, N., Cheav, S. L., Mouas, C., Swynghedauw, B., & Delcayre, C. (1994) · Hypertension · doi:10.1161/01.hyp.24.1.30 · Cited by 180
Reul, J. M. H. M., Pearce, P. T., Funder, J. W., & Krozowski, Z. S. (1989) · Molecular Endocrinology · doi:10.1210/mend-3-10-1674 · Cited by 178
Walker, B. R., Yau, J. L. W., Brett, L. P., Seckl, J. R., Monder, C., Williams, B. C., & Edwards, C. R. W. (1991) · Endocrinology · doi:10.1210/endo-129-6-3305 · Cited by 161
Lombès, M., Farman, N., Rafestin-Oblin, M. E., Baulieu, E. E., Bonvalet, J. P., Erlanger, B. F., & Gasc, J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.3.1086 · Cited by 141
Self-citationHIGH AFFINITY ALDOSTERONE BINDING SITES (TYPE I RECEPTORS) IN RAT HEART
Pearce, P., & Funder, J. W. (1987) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1987.tb02422.x · Cited by 130
Immunolocalization of gluco- and mineralocorticoid receptors in rabbit kidney
Farman, N., Rafestin-Oblin, M. E., Lombès, M., Delahaye, F., Westphal, H. M., Bonvalet, J. P., & Gasc, J. (1991) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1991.260.2.c226 · Cited by 130
Self-citationIkeda, U., Hyman, R., Smith, T. W., & Medford, R. M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99065-4 · Cited by 127
llβ-Hydroxysteroid Dehydrogenase Activity in the Renal Target Cells of Aldosterone*
Náray‐Fejes‐Tóth, A., Watlington, C. O., & Fejes‐Tóth, G. (1991) · Endocrinology · doi:10.1210/endo-129-1-17 · Cited by 119
11β‐hydroxysteroid dehydrogenase isoforms and their implications for blood pressure regulation
Seckl, J. R. (1993) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1993.tb00720.x · Cited by 111
Corticosteroid llβ-Dehydrogenase of Rat Tissues: Immunological Studies
Monder, C., & Lakshmi, V. M. (1990) · Endocrinology · doi:10.1210/endo-126-5-2435 · Cited by 108
Walker, B. R., Campbell, J. C., Williams, B. C., & Edwards, C. R. W. (1992) · Endocrinology · doi:10.1210/endo.131.2.1639034 · Cited by 96
Stumpf, W. E. (1990) · Cellular and Molecular Life Sciences · doi:10.1007/bf01955408 · Cited by 94
Distribution of 11 beta-hydroxysteroid dehydrogenase along the rabbit nephron.
Bonvalet, J. P., Doignon, I., Blot‐Chabaud, M., Pradelles, P., & Farman, N. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114781 · Cited by 83
Self-citationSlight, S. H., Ganjam, V. K., Nonneman, D., & Weber, K. T. (1993) · PubMed · Cited by 33
Detection of corticosteroid type I binding sites in heart
Barnett, C. A., & Pritchett, E. L. (1988) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(88)90060-3 · Cited by 31
Expression of 11β-OHSD along the nephron of mammals and humans
Kenouch, S., Alfaidy, N., Bonvalet, J. P., & Farman, N. (1994) · Steroids · doi:10.1016/0039-128x(94)90084-1 · Cited by 30
Self-citationCellular mechanisms of action of mineralocorticoid hormones
Johnson, J. P. (1992) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(92)90042-x · Cited by 30
Characteristics and regulation of 11β-hydroxysteroid dehydrogenase of proximal and distal nephron
Alfaidy, N., Blot‐Chabaud, M., Robic, D., Kenouch, S., Bourbouze, R., Bonvalet, J. P., & Farman, N. (1995) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(94)00173-u · Cited by 29
Self-citationPurification and characterization of the activated mineralocorticoid receptor from rat myocardium
Lázár, G., Pagano, M., & Agarwal, M. K. (1990) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(90)90192-y · Cited by 22
Cited by
Pathological Ventricular Remodeling: Mechanisms: Part 1 of 2
Burchfield, J. S., Xie, M., & Hill, J. A. (2013) · Circulation · doi:10.1161/circulationaha.113.001878 · Cited by 766
11β-Hydroxysteroid Dehydrogenase
Stewart, P. M., & Krozowski, Z. S. (1997) · Vitamins & Hormones · doi:10.1016/s0083-6729(08)60646-9 · Cited by 718
Aldosterone induces a vascular inflammatory phenotype in the rat heart
Rocha, R., Rudolph, A. E., Frierdich, G. E., Nachowiak, D. A., Kekec, B. K., Blomme, E. A. G., McMahon, E. G., & Delyani, J. A. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01096.2001 · Cited by 655
Glucocorticoids and cardiovascular disease
Walker, B. R. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0455 · Cited by 529
11β-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess*
White, P. C., Mune, T., & Agarwal, A. K. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0288 · Cited by 517
Metadata
- Authors
- Lombès, M., Alfaidy, N., Eugene, E., Lessana, A., Farman, N., & Bonvalet, J.-P.
- Venue
- Circulation
- Published
- 1995-07-15
- Volume
- 92
- Issue
- 2
- Pages
- 175-182
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1987089303
- Cited by
- 292
- References
- 34
- FWCI
- 4.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.